TABLE 3.
Mediuma | Inoculum (CFU/spot) | Incubation time (h) | MIC90, MIC90 range, or geometric mean MIC (μg/ml) for:
|
Reference | ||||
---|---|---|---|---|---|---|---|---|
Erythromycin | Rifampin | Ciprofloxacin | Levofloxacin | Dalfopristinquinupristin | ||||
BSYE | 104/105 | 48 | 0.12 | 0.002/0.008 | d.n.a.d | 0.015/0.03 | 0.5 | This study |
BCYE | 104 | 48 | 1 | ≤0.004 | d.n.a. | 0.125 | d.n.a. | 2e |
BCYE | 104 | 72 | d.n.a. | 0.03–0.125 | d.n.a. | d.n.a. | d.n.a. | 3e |
LHRC-BYE | 104 | 72 | d.n.a. | 0.00035–0.00075 | d.n.a. | d.n.a. | d.n.a. | 3e |
BAM1 | 6 × 105 | 72 | 0.25b | d.n.a. | d.n.a. | d.n.a. | d.n.a. | 4 |
BCYE | 6 × 105 | 72 | 0.12b | d.n.a. | d.n.a. | d.n.a. | d.n.a. | 4 |
BYE | 6 × 105 | 72 | 0.12b | d.n.a. | d.n.a. | d.n.a. | d.n.a. | 4 |
BCYE | 105 | 48 | 1 | 0.008 | 2 | d.n.a. | d.n.a. | 6 |
BSYE | 105 | 48 | 0.5 | ≤0.002 | 0.125 | d.n.a. | d.n.a. | 6 |
BYE | 104 | 48 | 0.25–1c | ≤0.004–0.008c | 0.01–0.12c | d.n.a. | 0.12–0.5c | 10e |
CYE | 104/105 | 72 | 0.25/0.5 | 0.125/0.125 | d.n.a. | d.n.a. | d.n.a. | 15e |
BCYE | 104 | 96 | ≥2 | 0.5 | 2 | d.n.a. | d.n.a. | 17 |
BSYE | 104 | 96 | 0.5 | ≤0.015 | ≤0.06 | d.n.a. | d.n.a. | 17 |
BSYE | 106 | 48 | 0.5 | 0.008 | 0.06 | d.n.a. | 1 | 24e |
BCYE | 104 | 48 | 1 | d.n.a. | 1 | 0.5 | d.n.a. | 29e |
BSYE | 106 | 48 | 0.06 | d.n.a. | 0.015 | 0.015 | d.n.a. | 29e |
Abbreviations: LHRC, lysed horse red cell; BYE, buffered yeast extract; BAM1, buffered antibiotic medium no. 1; CYE, charcoal-yeast extract.
Geometric mean MIC.
MIC90 range.
d.n.a., data not available.
Data for L. pneumophila.